Mayflower Financial Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,742
| Closed | -$648K | – | 350 |
|
|
2023
Q2 | $648K | Sell |
27,742
-6,594
| -19% | -$154K | 0.08% | 172 |
|
|
2023
Q1 | $799K | Buy |
34,336
+12,584
| +58% | +$293K | 0.11% | 152 |
|
|
2022
Q4 | $547K | Sell |
21,752
-1,601
| -7% | -$40.3K | 0.08% | 181 |
|
|
2022
Q3 | $616K | Sell |
23,353
-5,623
| -19% | -$148K | 0.1% | 149 |
|
|
2022
Q2 | $837K | Sell |
28,976
-45
| -0.2% | -$1.3K | 0.13% | 123 |
|
|
2022
Q1 | $1M | Buy |
29,021
+7,132
| +33% | +$246K | 0.13% | 112 |
|
|
2021
Q4 | $959K | Buy |
21,889
+3,122
| +17% | +$137K | 0.13% | 116 |
|
|
2021
Q3 | $924K | Buy |
18,767
+2,566
| +16% | +$126K | 0.12% | 114 |
|
|
2021
Q2 | $843K | Buy |
16,201
+595
| +4% | +$31K | 0.12% | 120 |
|
|
2021
Q1 | $713K | Buy |
+15,606
| New | +$713K | 0.11% | 128 |
|